As a novel target in melanoma drug development, ALOX5 has been described to promote autophagy-dependent ferroptosis by activating the AMP-activated protein kinase (AMPK) pathway in vitro and in vivo [180]. The gene discussed is ALOX5; the disease is melanoma.